2024 Medical Inhaler Trends Analysis, 2021-2027 China Medical Inhaler Market Analysis and Trends Report

返回首頁|排行榜|聯(lián)系我們|服務(wù)流程|繁體中文

訂閱Rss更新 下載電子版產(chǎn)業(yè)調(diào)研網(wǎng) > 調(diào)研報(bào)告 > 醫(yī)藥保健行業(yè) > 2021-2027 China Medical Inhaler Market Analysis and Trends Report

2021-2027 China Medical Inhaler Market Analysis and Trends Report

報(bào)告編號:3179996 CIR.cn ┊ 推薦:
  • 名 稱:2021-2027 China Medical Inhaler Market Analysis and Trends Report
  • 編 號:3179996 
  • 市場價(jià):電子版23300元  紙質(zhì)+電子版24300
  • 優(yōu)惠價(jià):電子版22300元  紙質(zhì)+電子版22600
  • 電 話:400 612 8668、010-6618 1099、66182099、66183099
  • 郵 箱:KF@Cir.cn  《訂購協(xié)議》下載
  • 提 示:如需中文、日文等其他語言版本,請與我們聯(lián)系。
  • 網(wǎng)上訂購  下載訂購協(xié)議  Pdf格式下載
2021-2027 China Medical Inhaler Market Analysis and Trends Report
字號: 報(bào)告內(nèi)容:

1 Introduction to Research & Analysis Reports

 1.1 Medical Inhaler Market Definition

 1.2 Market Segments

  1.2.1 Segment by Type
  1.2.2 Segment by Application

 1.3 China Medical Inhaler Market Overview

 1.4 Methodology & Sources of Information

  1.4.1 Research Methodology
  1.4.2 Research Process
  1.4.3 Base Year

2 China Medical Inhaler Overall Market Size

 2.1 China Medical Inhaler Market Size: 2021 VS 2027

 2.2 China Medical Inhaler Revenue, Prospects & Forecasts: 2016-2027

 2.3 China Medical Inhaler Sales: 2016-2027

3 Company Landscape

 3.1 Top Medical Inhaler Players in China Market

 3.2 Top China Medical Inhaler Companies Ranked by Revenue

 3.3 China Medical Inhaler Revenue by Companies

 3.4 China Medical Inhaler Sales by Companies

 3.5 China Medical Inhaler Price by Manufacturer (2016-2021)

 3.6 Top 3 and Top 5 Medical Inhaler Companies in China Market, by Revenue in 2020

 3.7 Manufacturers Medical Inhaler Product Type

 3.8 Tier 1, Tier 2 and Tier 3 Medical Inhaler Players in China Market

  3.8.1 List of Tier 1 Medical Inhaler Companies in China
  3.8.2 List of Tier 2 and Tier 3 Medical Inhaler Companies in China

4 Sights by Type

 4.1 Overview

  4.1.1 By Type - China Medical Inhaler Market Size Markets, 2021 & 2027
  4.1.2 Pressurised Metered Dose Inhaler (PMDI)
  4.1.3 Dry Powder Inhaler (DPI)
  4.1.4 Others

 4.2 By Type - China Medical Inhaler Revenue & Forecasts

  4.2.1 By Type - China Medical Inhaler Revenue, 2016-2021
  4.2.2 By Type - China Medical Inhaler Revenue, 2022-2027
全:文:http://www.miaohuangjin.cn/6/99/2021-2027-China-Medical-Inhaler-Market-Analysis-and-Trends-Report.html
  4.2.3 By Type - China Medical Inhaler Revenue Market Share, 2016-2027

 4.3 By Type - China Medical Inhaler Sales & Forecasts

  4.3.1 By Type - China Medical Inhaler Sales, 2016-2021
  4.3.2 By Type - China Medical Inhaler Sales, 2022-2027
  4.3.3 By Type - China Medical Inhaler Sales Market Share, 2016-2027

 4.4 By Type - China Medical Inhaler Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application

 5.1 Overview

  5.1.1 By Application - China Medical Inhaler Market Size, 2021 & 2027
  5.1.2 Asthma
  5.1.3 Chronic Obstructive Pulmonary Disease (COPD)
  5.1.4 Allergic Rhinitis

 5.2 By Application - China Medical Inhaler Revenue & Forecasts

  5.2.1 By Application - China Medical Inhaler Revenue, 2016-2021
  5.2.2 By Application - China Medical Inhaler Revenue, 2022-2027
  5.2.3 By Application - China Medical Inhaler Revenue Market Share, 2016-2027

 5.3 By Application - China Medical Inhaler Sales & Forecasts

  5.3.1 By Application - China Medical Inhaler Sales, 2016-2021
  5.3.2 By Application - China Medical Inhaler Sales, 2022-2027
  5.3.3 By Application - China Medical Inhaler Sales Market Share, 2016-2027

 5.4 By Application - China Medical Inhaler Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles

 6.1 GSK

  6.1.1 GSK Corporation Information
  6.1.2 GSK Overview
  6.1.3 GSK Medical Inhaler Sales and Revenue in China Market (2016-2021)
  6.1.4 GSK Medical Inhaler Product Description
  6.1.5 GSK Recent Developments

 6.2 AstraZeneca

  6.2.1 AstraZeneca Corporation Information
  6.2.2 AstraZeneca Overview
  6.2.3 AstraZeneca Medical Inhaler Sales and Revenue in China Market (2016-2021)
  6.2.4 AstraZeneca Medical Inhaler Product Description
  6.2.5 AstraZeneca Recent Developments

 6.3 Boehringer Ingelheim

  6.3.1 Boehringer Ingelheim Corporation Information
  6.3.2 Boehringer Ingelheim Overview
  6.3.3 Boehringer Ingelheim Medical Inhaler Sales and Revenue in China Market (2016-2021)
  6.3.4 Boehringer Ingelheim Medical Inhaler Product Description
  6.3.5 Boehringer Ingelheim Recent Developments

 6.4 Chiesi

  6.4.1 Chiesi Corporation Information
  6.4.2 Chiesi Overview
  6.4.3 Chiesi Medical Inhaler Sales and Revenue in China Market (2016-2021)
  6.4.4 Chiesi Medical Inhaler Product Description
  6.4.5 Chiesi Recent Developments

 6.5 Cipla

  6.5.1 Cipla Corporation Information
  6.5.2 Cipla Overview
  6.5.3 Cipla Medical Inhaler Sales and Revenue in China Market (2016-2021)
  6.5.4 Cipla Medical Inhaler Product Description
  6.5.5 Cipla Recent Developments

 6.6 3M

  6.6.1 3M Corporation Information
  6.6.2 3M Overview
  6.6.3 3M Medical Inhaler Sales and Revenue in China Market (2016-2021)
  6.6.4 3M Medical Inhaler Product Description
  6.6.5 3M Recent Developments

 6.7 Hovione

  6.7.1 Hovione Corporation Information
  6.7.2 Hovione Overview
  6.7.3 Hovione Medical Inhaler Sales and Revenue in China Market (2016-2021)
  6.7.4 Hovione Medical Inhaler Product Description
  6.7.5 Hovione Recent Developments

 6.8 Mannkind

  6.8.1 Mannkind Corporation Information
  6.8.2 Mannkind Overview
  6.8.3 Mannkind Medical Inhaler Sales and Revenue in China Market (2016-2021)
2021-2027年中國醫(yī)用吸入器市場分析及趨勢報(bào)告
  6.8.4 Mannkind Medical Inhaler Product Description
  6.8.5 Mannkind Recent Developments

 6.9 Mylan

  6.9.1 Mylan Corporation Information
  6.9.2 Mylan Overview
  6.9.3 Mylan Medical Inhaler Sales and Revenue in China Market (2016-2021)
  6.9.4 Mylan Medical Inhaler Product Description
  6.9.5 Mylan Recent Developments

 6.10 Novartis

  6.10.1 Novartis Corporation Information
  6.10.2 Novartis Overview
  6.10.3 Novartis Medical Inhaler Sales and Revenue in China Market (2016-2021)
  6.10.4 Novartis Medical Inhaler Product Description
  6.10.5 Novartis Recent Developments

 6.11 Teva

  6.11.1 Teva Corporation Information
  6.11.2 Teva Overview
  6.11.3 Teva Medical Inhaler Sales and Revenue in China Market (2016-2021)
  6.11.4 Teva Medical Inhaler Product Description
  6.11.5 Teva Recent Developments

 6.12 Vectura

  6.12.1 Vectura Corporation Information
  6.12.2 Vectura Overview
  6.12.3 Vectura Medical Inhaler Sales and Revenue in China Market (2016-2021)
  6.12.4 Vectura Medical Inhaler Product Description
  6.12.5 Vectura Recent Developments

 6.13 Adherium

  6.13.1 Adherium Corporation Information
  6.13.2 Adherium Overview
  6.13.3 Adherium Medical Inhaler Sales and Revenue in China Market (2016-2021)
  6.13.4 Adherium Medical Inhaler Product Description
  6.13.5 Adherium Recent Developments

 6.14 Cohero Health

  6.14.1 Cohero Health Corporation Information
  6.14.2 Cohero Health Overview
  6.14.3 Cohero Health Medical Inhaler Sales and Revenue in China Market (2016-2021)
  6.14.4 Cohero Health Medical Inhaler Product Description
  6.14.5 Cohero Health Recent Developments

 6.15 Opko

  6.15.1 Opko Corporation Information
  6.15.2 Opko Overview
  6.15.3 Opko Medical Inhaler Sales and Revenue in China Market (2016-2021)
  6.15.4 Opko Medical Inhaler Product Description
  6.15.5 Opko Recent Developments

 6.16 ResMed

  6.16.1 ResMed Corporation Information
  6.16.2 ResMed Overview
  6.16.3 ResMed Medical Inhaler Sales and Revenue in China Market (2016-2021)
  6.16.4 ResMed Medical Inhaler Product Description
  6.16.5 ResMed Recent Developments

 6.17 Beximco Pharma

  6.17.1 Beximco Pharma Corporation Information
  6.17.2 Beximco Pharma Overview
  6.17.3 Beximco Pharma Medical Inhaler Sales and Revenue in China Market (2016-2021)
  6.17.4 Beximco Pharma Medical Inhaler Product Description
  6.17.5 Beximco Pharma Recent Developments

7 China Medical Inhaler Production Capacity, Analysis

 7.1 China Medical Inhaler Production Capacity, 2016-2027

 7.2 Medical Inhaler Production Capacity of Key Manufacturers in China Market

8 Key Market Trends, Opportunity, Drivers and Restraints

 8.1 Market Opportunities & Trends

 8.2 Market Drivers

 8.3 Market Restraints

9 Medical Inhaler Supply Chain Analysis

 9.1 Medical Inhaler Industry Value Chain

2021-2027年中國醫(yī)用吸入器市場分析及趨勢報(bào)告

 9.2 Medical Inhaler Upstream Market

 9.3 Medical Inhaler Downstream and Clients

 9.4 Marketing Channels Analysis

  9.4.1 Marketing Channels
  9.4.2 Medical Inhaler Distributors and Sales Agents in China Market

10 Conclusion

11 Appendix

 11.1 Note

 11.2 Examples of Clients

 11.3 Author Details

 11.4 Disclaimer

List of Tables
 Table 1. Key Players of Medical Inhaler in China Market
 Table 2. Top Medical Inhaler Players in China Market, Ranking by Revenue (2019)
 Table 3. China Medical Inhaler Revenue by Companies, (US$, Mn), 2016-2021
 Table 4. China Medical Inhaler Revenue Share by Companies, 2016-2021
 Table 5. China Medical Inhaler Sales by Companies, (K Units), 2016-2021
 Table 6. China Medical Inhaler Sales Share by Companies, 2016-2021
 Table 7. Key Manufacturers Medical Inhaler Price (2016-2021) & (US$/Unit)
 Table 8. Manufacturers Medical Inhaler Product Type
 Table 9. List of Tier 1 Medical Inhaler Companies, Revenue (US$, Mn) in 2020 and Market Share
 Table 10. List of Tier 2 and Tier 3 Medical Inhaler Companies, Revenue (US$, Mn) in 2020 and Market Share
 Table 11. Major Manufacturers of Pressurised Metered Dose Inhaler (PMDI)
 Table 12. Major Manufacturers of Dry Powder Inhaler (DPI)
 Table 13. By Type – China Medical Inhaler Revenue, (US$, Mn), 2021 & 2027
 Table 14. By Type - China Medical Inhaler Revenue (US$, Mn), 2016-2021
 Table 15. By Type - China Medical Inhaler Revenue (US$, Mn), 2022-2027
 Table 16. By Type - China Medical Inhaler Sales (K Units), 2016-2021
 Table 17. By Type - China Medical Inhaler Sales (K Units), 2022-2027
 Table 18. By Application – China Medical Inhaler Revenue, (US$, Mn), 2021 VS 2027
 Table 19. By Application - China Medical Inhaler Revenue (US$, Mn), 2016-2021
 Table 20. By Application - China Medical Inhaler Revenue (US$, Mn), 2022-2027
 Table 21. By Application - China Medical Inhaler Sales (K Units), 2016-2021
 Table 22. By Application - China Medical Inhaler Sales (K Units), 2022-2027
 Table 23. GSK Corporation Information
 Table 24. GSK Description and Major Businesses
 Table 25. GSK Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
 Table 26. GSK Medical Inhaler Product
 Table 27. GSK Recent Developments
 Table 28. AstraZeneca Corporation Information
 Table 29. AstraZeneca Description and Major Businesses
 Table 30. AstraZeneca Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
 Table 31. AstraZeneca Medical Inhaler Product
 Table 32. AstraZeneca Recent Developments
 Table 33. Boehringer Ingelheim Corporation Information
 Table 34. Boehringer Ingelheim Description and Major Businesses
 Table 35. Boehringer Ingelheim Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
 Table 36. Boehringer Ingelheim Medical Inhaler Product
 Table 37. Boehringer Ingelheim Recent Developments
 Table 38. Chiesi Corporation Information
 Table 39. Chiesi Description and Major Businesses
 Table 40. Chiesi Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
 Table 41. Chiesi Medical Inhaler Product
 Table 42. Chiesi Recent Developments
 Table 43. Cipla Corporation Information
 Table 44. Cipla Description and Major Businesses
 Table 45. Cipla Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
 Table 46. Cipla Medical Inhaler Product
 Table 47. Cipla Recent Developments
 Table 48. 3M Corporation Information
 Table 49. 3M Description and Major Businesses
 Table 50. 3M Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
 Table 51. 3M Medical Inhaler Product
 Table 52. 3M Recent Developments
 Table 53. Hovione Corporation Information
 Table 54. Hovione Description and Major Businesses
 Table 55. Hovione Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
2021-2027 Nian Zhong Guo Yi Yong Xi Ru Qi Shi Chang FenXi Ji Qu Shi Bao Gao
 Table 56. Hovione Medical Inhaler Product
 Table 57. Hovione Recent Developments
 Table 58. Mannkind Corporation Information
 Table 59. Mannkind Description and Major Businesses
 Table 60. Mannkind Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
 Table 61. Mannkind Medical Inhaler Product
 Table 62. Mannkind Recent Developments
 Table 63. Mylan Corporation Information
 Table 64. Mylan Description and Major Businesses
 Table 65. Mylan Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
 Table 66. Mylan Medical Inhaler Product
 Table 67. Mylan Recent Developments
 Table 68. Novartis Corporation Information
 Table 69. Novartis Description and Major Businesses
 Table 70. Novartis Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
 Table 71. Novartis Medical Inhaler Product
 Table 72. Novartis Recent Developments
 Table 73. Teva Corporation Information
 Table 74. Teva Description and Major Businesses
 Table 75. Teva Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
 Table 76. Teva Medical Inhaler Product
 Table 77. Teva Recent Developments
 Table 78. Vectura Corporation Information
 Table 79. Vectura Description and Major Businesses
 Table 80. Vectura Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
 Table 81. Vectura Medical Inhaler Product
 Table 82. Vectura Recent Developments
 Table 83. Adherium Corporation Information
 Table 84. Adherium Description and Major Businesses
 Table 85. Adherium Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
 Table 86. Adherium Medical Inhaler Product
 Table 87. Adherium Recent Developments
 Table 88. Cohero Health Corporation Information
 Table 89. Cohero Health Description and Major Businesses
 Table 90. Cohero Health Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
 Table 91. Cohero Health Medical Inhaler Product
 Table 92. Cohero Health Recent Developments
 Table 93. Opko Corporation Information
 Table 94. Opko Description and Major Businesses
 Table 95. Opko Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
 Table 96. Opko Medical Inhaler Product
 Table 97. Opko Recent Developments
 Table 98. ResMed Corporation Information
 Table 99. ResMed Description and Major Businesses
 Table 100. ResMed Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
 Table 101. ResMed Medical Inhaler Product
 Table 102. ResMed Recent Developments
 Table 103. Beximco Pharma Corporation Information
 Table 104. Beximco Pharma Description and Major Businesses
 Table 105. Beximco Pharma Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
 Table 106. Beximco Pharma Medical Inhaler Product
 Table 107. Beximco Pharma Recent Developments
 Table 108. Medical Inhaler Production Capacity (K Units) of Key Manufacturers in China Market, 2019-2021 (K Units)
 Table 109. China Medical Inhaler Capacity Market Share of Key Manufacturers, 2019-2021
 Table 110. Medical Inhaler Market Opportunities & Trends in China Market
 Table 111. Medical Inhaler Market Drivers in China Market
 Table 112. Medical Inhaler Market Restraints in China Market
 Table 113. Medical Inhaler Raw Materials
 Table 114. Medical Inhaler Raw Materials Suppliers in China Market
 Table 115. Typical Medical Inhaler Downstream
 Table 116. Medical Inhaler Downstream Clients in China Market
 Table 117. Medical Inhaler Distributors and Sales Agents in China Market
List of Figures
 Figure 1. Medical Inhaler Product Picture
 Figure 2. Medical Inhaler Segment by Type
 Figure 3. Medical Inhaler Segment by Application
 Figure 4. China Medical Inhaler Market Overview: 2020
2021-2027中國醫(yī)療吸入器市場分析と動(dòng)向レポート
 Figure 5. China Medical Inhaler Market Size: 2021 VS 2027 (US$, Mn)
 Figure 6. China Medical Inhaler Revenue, 2016-2027 (US$, Mn)
 Figure 7. Medical Inhaler Sales in China Market: 2016-2027 (K Units)
 Figure 8. The Top 3 and 5 Players Market Share by Medical Inhaler Revenue in 2020
 Figure 9. Pressurised Metered Dose Inhaler (PMDI) Product Picture
 Figure 10. Dry Powder Inhaler (DPI) Product Picture
 Figure 11. Others Product Picture
 Figure 12. By Type - China Medical Inhaler Sales Market Share, 2016-2027
 Figure 13. By Type - China Medical Inhaler Revenue Market Share, 2016-2027
 Figure 14. By Type - China Medical Inhaler Price (US$/Unit), 2016-2027
 Figure 15. Asthma
 Figure 16. Chronic Obstructive Pulmonary Disease (COPD)
 Figure 17. Allergic Rhinitis
 Figure 18. By Application - China Medical Inhaler Sales Market Share, 2016-2027
 Figure 19. By Application - China Medical Inhaler Revenue Market Share, 2016-2027
 Figure 20. By Application - China Medical Inhaler Price (US$/Unit), 2016-2027
 Figure 21. GSK Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
 Figure 22. AstraZeneca Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
 Figure 23. Boehringer Ingelheim Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
 Figure 24. Chiesi Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
 Figure 25. Cipla Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
 Figure 26. 3M Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
 Figure 27. Hovione Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
 Figure 28. Mannkind Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
 Figure 29. Mylan Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
 Figure 30. Novartis Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
 Figure 31. Teva Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
 Figure 32. Vectura Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
 Figure 33. Adherium Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
 Figure 34. Cohero Health Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
 Figure 35. Opko Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
 Figure 36. ResMed Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
 Figure 37. Beximco Pharma Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
 Figure 38. China Medical Inhaler Production Capacity (K Units), 2016-2027
 Figure 39. Medical Inhaler Industry Value Chain
 Figure 40. Marketing Channels

  

  

  …

掃一掃 “2021-2027 China Medical Inhaler Market Analysis and Trends Report”

如需購買《2021-2027 China Medical Inhaler Market Analysis and Trends Report》,編號:3179996
請您致電:400 612 8668、010-6618 1099、66182099、66183099
或Email至:KF@Cir.cn  【網(wǎng)上訂購】下載《訂購協(xié)議》了解“訂購流程”
昌图县| 邓州市| 理塘县| 北安市| 绥芬河市| 永平县| 汝南县| 临邑县| 永年县| 古蔺县| 黎平县| 吉隆县| 文山县| 安新县| 赤壁市| 长沙市| 磐安县| 鞍山市| 淮安市| 湾仔区| 栾城县| 林周县| 鸡东县| 贡觉县| 龙游县| 玉林市| 晋江市| 浦城县| 平江县| 陆良县| 太仆寺旗| 田阳县| 云林县| 那坡县| 东兰县| 安宁市| 永兴县| 资源县| 聂拉木县| 七台河市| 凤台县|